data_1n3h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n3h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.819 0.342 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.16 29.83 6.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -119.45 -74.91 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.45 -57.12 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 t -79.58 79.28 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.77 -134.71 43.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 166.05 14.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.45 -156.25 44.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.515 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.85 -112.31 0.26 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 62.13 160.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.69 142.51 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -148.89 -58.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 66.66 -179.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -88.33 139.9 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.084 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.57 169.64 17.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.9 128.67 9.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.1 34.45 1.54 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.7 76.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -116.74 106.39 13.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.78 -86.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.514 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.83 141.06 4.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -50.35 -54.62 20.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.28 110.29 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.3 m0 62.89 137.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.79 102.34 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.23 35.63 1.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -106.47 168.84 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.42 148.07 23.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.449 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -140.83 92.11 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.0 110.985 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 29.8 p90 -108.81 96.22 6.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.67 114.51 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.4 t30 52.78 81.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 1.1 mttm 178.05 -52.01 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 33' ' ' LYS . 39.7 Cg_exo -60.73 166.93 9.26 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -152.84 68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.61 157.86 43.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.073 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.48 177.95 28.23 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.416 ' CD2' HG22 ' A' ' 126' ' ' VAL . 5.4 t-105 -50.98 115.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.709 0.29 . . . . 0.0 110.816 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HA ' ' CD1' ' A' ' 194' ' ' ILE . 0.8 OUTLIER 68.7 -67.08 0.22 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.12 0.486 . . . . 0.0 110.556 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.48 ' CD2' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -133.66 174.26 4.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD2' ' CD2' ' A' ' 40' ' ' HIS . 69.6 Cg_exo -38.88 156.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.639 2.226 . . . . 0.0 112.443 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 46' ' ' MET . 79.2 m-20 -41.4 -39.04 1.36 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.771 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.442 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -50.21 -38.24 39.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.661 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -23.84 65.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.647 0.26 . . . . 0.0 111.606 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -95.61 -67.23 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.976 0.417 . . . . 0.0 111.044 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.427 ' HE1' ' N ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -54.67 -19.53 6.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -177.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.56 -80.52 1.5 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.177 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' O ' ' A' ' 43' ' ' ASP . 88.9 Cg_endo -85.28 -20.47 3.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.189 2.593 . . . . 0.0 112.773 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 138.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.135 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 1.6 t -95.88 94.37 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.599 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 7.7 p -114.82 137.89 51.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.115 0.483 . . . . 0.0 111.531 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' HB3' ' N ' ' A' ' 186' ' ' LEU . 1.8 m-85 -145.84 164.45 31.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.861 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -76.34 131.25 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.246 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -148.42 135.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.192 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.62 104.98 12.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.25 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.13 135.08 46.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.79 108.65 13.26 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.893 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 17.84 -136.43 0.01 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 124.396 1.06 . . . . 0.0 115.149 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 178' ' ' HIS . 18.6 p -148.38 124.77 10.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.726 0.298 . . . . 0.0 111.221 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 179' ' ' ILE . 16.9 m -92.99 112.01 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -85.23 147.58 26.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.06 117.09 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.242 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.51 41.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.72 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.404 ' CB ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -64.16 157.9 24.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.085 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 m -98.67 -171.18 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.746 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.4 mmt -93.62 32.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.173 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.74 60.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 109' ' ' ILE . . . -105.93 151.39 24.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' CD2' ' NE2' ' A' ' 76' ' ' GLN . 0.6 OUTLIER 59.65 141.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.422 178.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' A' ' 69' ' ' LEU . 1.3 m-20 -85.06 63.09 7.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.911 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.74 -66.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.376 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 73' ' ' THR . 11.2 m120 -164.36 -40.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.467 ' HA ' ' CG ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER 86.94 5.05 0.35 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.132 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -55.77 -62.43 1.7 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.554 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 76' ' ' GLN . 28.1 p -56.26 -67.18 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.212 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.487 ' CB ' ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -36.72 -57.22 0.8 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.035 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' CG2' HG23 ' A' ' 73' ' ' THR . 58.4 t -57.1 -75.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.235 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 -41.43 31.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.59 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.058 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.4 tp10 -77.81 -23.8 48.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.63 36.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.433 HG12 ' CD1' ' A' ' 179' ' ' ILE . 58.1 mt -69.08 -52.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.339 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 95' ' ' ALA . 45.6 t -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.977 0.418 . . . . 0.0 109.911 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 12.6 tp -74.48 -44.93 49.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.667 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 86' ' ' CYS . 8.0 p -58.58 -26.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.751 0.31 . . . . 0.0 110.317 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.44 ' N ' HG11 ' A' ' 85' ' ' VAL . 3.7 m -75.69 -43.9 44.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.827 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -53.83 -31.61 49.94 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 115' ' ' LEU . . . -80.62 -62.79 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.207 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 118' ' ' ALA . 6.3 p -111.63 70.23 0.85 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.277 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 86' ' ' CYS . 30.1 Cg_endo -62.65 -11.91 25.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.649 2.233 . . . . 0.0 112.802 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.97 -25.26 7.25 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.058 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -103.49 84.67 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.586 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -44.03 120.6 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.8 -63.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.212 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 83' ' ' SER . . . -119.18 -31.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.712 0.292 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 t -137.19 -158.0 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 170.8 142.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.3 -71.81 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.025 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -163.72 165.23 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.102 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -177.53 134.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.72 -66.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.436 2.091 . . . . 0.0 112.348 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 m 51.88 176.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.74 -82.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -159.12 155.87 25.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.487 ' CB ' ' CB ' ' A' ' 76' ' ' GLN . 9.8 Cg_endo -51.95 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.731 2.287 . . . . 0.0 112.827 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -56.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.669 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.7 t -92.4 -160.51 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.524 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.44 -1.5 18.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.264 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -63.5 161.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 0.2 OUTLIER 83.47 142.76 0.07 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.343 -178.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.27 -71.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.894 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.11 138.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.922 0.361 . . . . 0.0 111.638 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.408 ' HB3' HD23 ' A' ' 84' ' ' LEU . 18.3 p -99.64 134.4 42.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.264 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -97.43 129.74 44.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -111.9 64.11 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -55.0 5.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.97 0.415 . . . . 0.0 110.479 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -143.21 61.26 1.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.311 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 89' ' ' VAL . . . -73.77 151.31 40.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.811 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.33 65.61 3.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.828 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.463 ' CE ' ' CG2' ' A' ' 122' ' ' ILE . 5.7 ttt -125.51 106.98 26.83 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 120.511 0.196 . . . . 0.0 110.688 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.421 ' O ' ' CG2' ' A' ' 122' ' ' ILE . 58.3 Cg_exo -57.22 122.56 12.01 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.347 2.031 . . . . 0.0 112.6 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.463 ' CG2' ' CE ' ' A' ' 120' ' ' MET . 1.5 pp -155.13 163.51 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.087 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.98 108.75 20.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.058 0.456 . . . . 0.0 111.239 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.437 HD23 ' CD2' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -92.57 126.19 37.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.251 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.425 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 63.7 m -109.77 121.35 45.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.993 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 50' ' ' VAL . 12.1 p -101.62 126.81 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.23 161.8 33.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.606 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -54.56 104.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.019 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.423 ' CB ' HD11 ' A' ' 200' ' ' LEU . 66.7 m 56.42 50.86 12.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.94 109.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.437 ' CD2' HD23 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -116.16 112.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.64 135.09 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.406 HD11 HD21 ' A' ' 124' ' ' LEU . 7.7 mp -105.9 158.34 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' A' ' 141' ' ' ILE . 0.8 OUTLIER -139.49 114.22 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 140' ' ' GLN . . . -57.24 109.62 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.668 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 122' ' ' ILE . . . -73.61 -60.18 2.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.424 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.23 -38.35 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.42 -19.7 62.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.519 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 mttm 68.45 48.11 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.849 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' A' ' 135' ' ' ALA . 14.3 pt20 -159.66 -168.93 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.333 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 134' ' ' MET . 6.6 mt -132.41 139.72 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.814 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 142' ' ' ILE . 0.0 OUTLIER -101.96 125.69 56.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.6 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -106.06 111.69 24.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.41 91.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -136.34 56.91 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -33.49 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.049 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.4 mtt -122.61 146.79 47.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.56 68.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.739 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.94 105.58 6.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.973 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 150' ' ' ILE . 0.1 OUTLIER -143.47 94.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.4 p -126.11 -83.13 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.04 126.44 51.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 175.09 -64.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.5 t -161.61 62.37 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -48.53 -51.19 22.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.67 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.75 44.21 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.404 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 158' ' ' PRO . 2.3 m-20 -154.76 -66.82 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.46 0.172 . . . . 0.0 111.158 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 157' ' ' ASP . 73.4 Cg_endo -76.02 95.11 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.345 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' ' CG2' ' A' ' 160' ' ' THR . 0.6 OUTLIER -157.2 -59.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 159' ' ' ASP . 0.8 OUTLIER -172.48 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -174.8 -67.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.151 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.21 42.29 3.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -133.32 144.34 49.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 190' ' ' VAL . 2.3 t -101.47 126.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.272 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -115.64 140.74 48.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 180' ' ' LEU . 2.7 m-85 -119.64 159.02 25.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.991 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.4 p -129.22 134.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -144.15 110.43 5.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -149.91 80.59 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.457 ' CB ' ' CD ' ' A' ' 171' ' ' PRO . 0.4 OUTLIER -75.29 -64.03 0.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.767 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 170' ' ' ASP . 98.8 Cg_endo -78.17 177.37 8.86 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.227 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.02 41.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.82 41.04 1.01 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 180.0 -79.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HB2' ' NH1' ' A' ' 175' ' ' ARG . 2.3 mtp-105 54.0 103.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -137.71 161.92 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 87.6 m -120.8 162.89 19.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 9.3 m-70 -130.75 157.42 42.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.611 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.433 ' CD1' HG12 ' A' ' 82' ' ' ILE . 49.5 mm -115.88 148.64 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.742 0.306 . . . . 0.0 111.068 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 166' ' ' TYR . 1.1 tt -148.01 150.11 33.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.43 ' N ' ' HG ' ' A' ' 180' ' ' LEU . 2.9 tt0 -120.7 129.54 53.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 190' ' ' VAL . 71.5 m -103.47 100.72 19.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 184' ' ' GLU . 94.5 Cg_endo -85.41 64.32 5.89 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.797 2.331 . . . . 0.0 111.923 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 183' ' ' PRO . 3.1 mt-10 68.72 45.18 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 52' ' ' TYR . . . -132.38 -103.62 0.89 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.803 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.438 ' N ' ' HB3' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -59.17 -18.81 39.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.294 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.463 ' HA ' ' CG2' ' A' ' 190' ' ' VAL . . . -33.88 -33.17 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.599 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 186' ' ' LEU . 9.5 mt-30 -52.16 -47.77 65.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.567 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 193' ' ' THR . 5.3 t70 -90.23 -41.82 11.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.463 ' CG2' ' HA ' ' A' ' 187' ' ' ALA . 13.4 m -69.39 -14.89 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 187' ' ' ALA . 4.3 tp -92.13 -44.41 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.15 -29.93 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.484 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 189' ' ' ASP . 3.1 m 68.8 56.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 110.478 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 3.6 mp -44.64 -42.09 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.509 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -162.1 -143.51 3.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 198' ' ' PHE . 0.6 OUTLIER -166.68 115.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.773 0.32 . . . . 0.0 110.849 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.43 82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 196' ' ' GLN . 0.2 OUTLIER -134.34 108.53 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.245 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.45 -70.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.508 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.423 HD11 ' CB ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 40.34 98.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.113 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 -49.7 -27.88 5.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.79 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -117.95 170.88 8.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.742 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -48.55 -79.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.39 -65.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.8 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.68 -53.28 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 42.5 mt 59.81 27.35 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.913 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.819 0.342 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.16 29.83 6.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -119.45 -74.91 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.45 -57.12 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 t -79.58 79.28 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.77 -134.71 43.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 166.05 14.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.45 -156.25 44.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.515 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.85 -112.31 0.26 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 62.13 160.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.69 142.51 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -148.89 -58.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 66.66 -179.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -88.33 139.9 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.084 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.57 169.64 17.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.9 128.67 9.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.1 34.45 1.54 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.7 76.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -116.74 106.39 13.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.78 -86.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.514 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.83 141.06 4.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -50.35 -54.62 20.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.28 110.29 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.3 m0 62.89 137.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.79 102.34 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.23 35.63 1.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -106.47 168.84 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.42 148.07 23.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.449 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -140.83 92.11 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.0 110.985 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 29.8 p90 -108.81 96.22 6.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.67 114.51 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.4 t30 52.78 81.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 1.1 mttm 178.05 -52.01 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 33' ' ' LYS . 39.7 Cg_exo -60.73 166.93 9.26 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 35' ' ' THR . 95.0 m -152.84 68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.61 157.86 43.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.073 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.48 177.95 28.23 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.742 ' CD2' HG21 ' A' ' 126' ' ' VAL . 5.4 t-105 -50.98 115.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.709 0.29 . . . . 0.0 110.816 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.921 ' HA ' HD13 ' A' ' 194' ' ' ILE . 0.8 OUTLIER 68.7 -67.08 0.22 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.12 0.486 . . . . 0.0 110.556 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.429 ' CB ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -133.66 174.26 4.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 40' ' ' HIS . 69.6 Cg_exo -38.88 156.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.639 2.226 . . . . 0.0 112.443 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 45' ' ' VAL . 79.2 m-20 -41.4 -39.04 1.36 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.771 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.543 ' N ' ' HE2' ' A' ' 46' ' ' MET . 0.3 OUTLIER -50.21 -38.24 39.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.661 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HD3' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -67.88 -23.84 65.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.647 0.26 . . . . 0.0 111.606 -179.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 197' ' ' ALA . 0.1 OUTLIER -95.61 -67.23 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.976 0.417 . . . . 0.0 111.044 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.543 ' HE2' ' N ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -54.67 -19.53 6.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -177.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.56 -80.52 1.5 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.177 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 43' ' ' ASP . 88.9 Cg_endo -85.28 -20.47 3.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.189 2.593 . . . . 0.0 112.773 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 138.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.135 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.966 ' O ' HG12 ' A' ' 126' ' ' VAL . 1.6 t -95.88 94.37 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.599 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 7.7 p -114.82 137.89 51.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.115 0.483 . . . . 0.0 111.531 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' HB3' ' N ' ' A' ' 186' ' ' LEU . 1.8 m-85 -145.84 164.45 31.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.861 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 54' ' ' VAL . 1.4 tm? -76.34 131.25 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.246 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.823 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -148.42 135.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.192 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.62 104.98 12.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.25 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.13 135.08 46.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.46 ' HG3' HG22 ' A' ' 179' ' ' ILE . 0.0 OUTLIER -122.79 108.65 13.26 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.893 -177.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 17.84 -136.43 0.01 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 124.396 1.06 . . . . 0.0 115.149 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 178' ' ' HIS . 18.6 p -148.38 124.77 10.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.726 0.298 . . . . 0.0 111.221 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 179' ' ' ILE . 16.9 m -92.99 112.01 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 1.2 tt0 -85.23 147.58 26.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG13 ' H ' ' A' ' 110' ' ' LEU . 21.6 t -143.06 117.09 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.242 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.51 41.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.72 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.765 ' CB ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -64.16 157.9 24.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.085 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 m -98.67 -171.18 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.746 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.4 mmt -93.62 32.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.173 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.74 60.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.503 ' CB ' HG23 ' A' ' 109' ' ' ILE . . . -105.93 151.39 24.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.85 HD13 ' N ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 59.65 141.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.422 178.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.85 ' N ' HD13 ' A' ' 69' ' ' LEU . 1.3 m-20 -85.06 63.09 7.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.911 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.74 -66.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.376 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 73' ' ' THR . 11.2 m120 -164.36 -40.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 1.09 HG21 HG21 ' A' ' 109' ' ' ILE . 0.2 OUTLIER 86.94 5.05 0.35 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.132 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HG2' ' HB3' ' A' ' 72' ' ' ASN . 21.4 mmt180 -55.77 -62.43 1.7 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.554 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 76' ' ' GLN . 28.1 p -56.26 -67.18 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.212 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.732 ' NE2' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -36.72 -57.22 0.8 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.035 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.896 HG23 HG22 ' A' ' 73' ' ' THR . 58.4 t -57.1 -75.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.235 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 -41.43 31.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.59 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.058 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.4 tp10 -77.81 -23.8 48.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.468 ' HB1' ' HB ' ' A' ' 60' ' ' VAL . . . -70.37 -50.63 36.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.917 ' O ' HG12 ' A' ' 85' ' ' VAL . 58.1 mt -69.08 -52.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.339 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.697 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 45.6 t -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.977 0.418 . . . . 0.0 109.911 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' N ' ' A' ' 113' ' ' SER . 12.6 tp -74.48 -44.93 49.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.667 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.917 HG12 ' O ' ' A' ' 82' ' ' ILE . 8.0 p -58.58 -26.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.751 0.31 . . . . 0.0 110.317 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.823 ' HB2' HG22 ' A' ' 96' ' ' THR . 3.7 m -75.69 -43.9 44.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.827 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -53.83 -31.61 49.94 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.069 ' HB1' HD22 ' A' ' 115' ' ' LEU . . . -80.62 -62.79 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.207 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.744 HG11 ' CB ' ' A' ' 118' ' ' ALA . 6.3 p -111.63 70.23 0.85 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.277 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 86' ' ' CYS . 30.1 Cg_endo -62.65 -11.91 25.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.649 2.233 . . . . 0.0 112.802 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.97 -25.26 7.25 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.058 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -103.49 84.67 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.586 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -44.03 120.6 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.8 -63.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.212 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 83' ' ' SER . . . -119.18 -31.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.712 0.292 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.823 HG22 ' HB2' ' A' ' 86' ' ' CYS . 4.4 t -137.19 -158.0 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.485 ' N ' HG23 ' A' ' 96' ' ' THR . 4.4 ttt180 170.8 142.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.147 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.3 -71.81 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.025 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -163.72 165.23 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.102 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -177.53 134.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 31.5 Cg_exo -58.72 -66.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.436 2.091 . . . . 0.0 112.348 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 m 51.88 176.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.74 -82.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -159.12 155.87 25.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HG2' HD11 ' A' ' 109' ' ' ILE . 9.8 Cg_endo -51.95 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.731 2.287 . . . . 0.0 112.827 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -56.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.669 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 6.7 t -92.4 -160.51 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.524 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.44 -1.5 18.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.264 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.09 HG21 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -63.5 161.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.689 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER 83.47 142.76 0.07 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.343 -178.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.27 -71.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.894 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -177.11 138.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.922 0.361 . . . . 0.0 111.638 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.515 ' N ' HD21 ' A' ' 84' ' ' LEU . 18.3 p -99.64 134.4 42.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.264 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -97.43 129.74 44.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.069 HD22 ' HB1' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -111.9 64.11 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -55.0 5.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.97 0.415 . . . . 0.0 110.479 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -143.21 61.26 1.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.311 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.744 ' CB ' HG11 ' A' ' 89' ' ' VAL . . . -73.77 151.31 40.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.811 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.33 65.61 3.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.828 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.676 ' HE1' HG21 ' A' ' 122' ' ' ILE . 5.7 ttt -125.51 106.98 26.83 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 120.511 0.196 . . . . 0.0 110.688 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.427 ' C ' HG23 ' A' ' 122' ' ' ILE . 58.3 Cg_exo -57.22 122.56 12.01 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.347 2.031 . . . . 0.0 112.6 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.676 HG21 ' HE1' ' A' ' 120' ' ' MET . 1.5 pp -155.13 163.51 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.087 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.98 108.75 20.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.058 0.456 . . . . 0.0 111.239 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.71 HD21 HD23 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -92.57 126.19 37.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.251 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.45 ' N ' HD23 ' A' ' 124' ' ' LEU . 63.7 m -109.77 121.35 45.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.993 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.015 HG23 HD11 ' A' ' 131' ' ' LEU . 12.1 p -101.62 126.81 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.23 161.8 33.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.606 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.575 ' HA ' ' HB1' ' A' ' 197' ' ' ALA . 1.3 p -54.56 104.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.019 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' HD12 ' A' ' 200' ' ' LEU . 66.7 m 56.42 50.86 12.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.94 109.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -116.16 112.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.64 135.09 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD12 HD23 ' A' ' 124' ' ' LEU . 7.7 mp -105.9 158.34 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 141' ' ' ILE . 0.8 OUTLIER -139.49 114.22 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.869 ' HB1' ' HB2' ' A' ' 138' ' ' CYS . . . -57.24 109.62 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.668 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 122' ' ' ILE . . . -73.61 -60.18 2.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.424 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.23 -38.35 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.869 ' HB2' ' HB1' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -61.42 -19.7 62.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.519 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 138' ' ' CYS . 4.4 mttm 68.45 48.11 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.849 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' ' 135' ' ' ALA . 14.3 pt20 -159.66 -168.93 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.333 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 134' ' ' MET . 6.6 mt -132.41 139.72 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.814 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -101.96 125.69 56.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.6 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -106.06 111.69 24.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.41 91.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -136.34 56.91 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -33.49 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.049 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.4 mtt -122.61 146.79 47.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.56 68.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.739 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.94 105.58 6.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.973 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' ' 150' ' ' ILE . 0.1 OUTLIER -143.47 94.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.4 p -126.11 -83.13 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 153' ' ' ALA . 0.9 OUTLIER -104.04 126.44 51.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 167' ' ' VAL . . . 175.09 -64.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.5 t -161.61 62.37 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -48.53 -51.19 22.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.67 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.75 44.21 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.404 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 158' ' ' PRO . 2.3 m-20 -154.76 -66.82 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.46 0.172 . . . . 0.0 111.158 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 157' ' ' ASP . 73.4 Cg_endo -76.02 95.11 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.345 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 160' ' ' THR . 0.6 OUTLIER -157.2 -59.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 159' ' ' ASP . 0.8 OUTLIER -172.48 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -174.8 -67.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.151 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.21 42.29 3.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -133.32 144.34 49.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 190' ' ' VAL . 2.3 t -101.47 126.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.272 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.694 ' HB2' HD11 ' A' ' 82' ' ' ILE . . . -115.64 140.74 48.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.512 ' OH ' HD22 ' A' ' 180' ' ' LEU . 2.7 m-85 -119.64 159.02 25.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.991 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 153' ' ' ALA . 13.4 p -129.22 134.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -144.15 110.43 5.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -149.91 80.59 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.469 ' CB ' ' HD3' ' A' ' 171' ' ' PRO . 0.4 OUTLIER -75.29 -64.03 0.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.767 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 170' ' ' ASP . 98.8 Cg_endo -78.17 177.37 8.86 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.227 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 172' ' ' VAL . 14.8 p -113.02 41.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.82 41.04 1.01 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 180.0 -79.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.453 ' HB2' ' NH1' ' A' ' 175' ' ' ARG . 2.3 mtp-105 54.0 103.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -137.71 161.92 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 60' ' ' VAL . 87.6 m -120.8 162.89 19.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 9.3 m-70 -130.75 157.42 42.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.611 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.69 HD12 HG12 ' A' ' 82' ' ' ILE . 49.5 mm -115.88 148.64 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.742 0.306 . . . . 0.0 111.068 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.577 HD11 ' HB ' ' A' ' 54' ' ' VAL . 1.1 tt -148.01 150.11 33.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.443 ' N ' ' HG ' ' A' ' 180' ' ' LEU . 2.9 tt0 -120.7 129.54 53.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.767 ' SG ' HG21 ' A' ' 190' ' ' VAL . 71.5 m -103.47 100.72 19.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 94.5 Cg_endo -85.41 64.32 5.89 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.797 2.331 . . . . 0.0 111.923 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 68.72 45.18 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 52' ' ' TYR . . . -132.38 -103.62 0.89 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.803 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 1.098 HD12 HG13 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -59.17 -18.81 39.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.294 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.655 ' HA ' HG22 ' A' ' 190' ' ' VAL . . . -33.88 -33.17 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.599 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 186' ' ' LEU . 9.5 mt-30 -52.16 -47.77 65.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.567 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.623 ' HA ' HD12 ' A' ' 194' ' ' ILE . 5.3 t70 -90.23 -41.82 11.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 1.098 HG13 HD12 ' A' ' 186' ' ' LEU . 13.4 m -69.39 -14.89 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 187' ' ' ALA . 4.3 tp -92.13 -44.41 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -109.15 -29.93 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.484 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 189' ' ' ASP . 3.1 m 68.8 56.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 110.478 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.921 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.6 mp -44.64 -42.09 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.509 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -162.1 -143.51 3.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 198' ' ' PHE . 0.6 OUTLIER -166.68 115.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.773 0.32 . . . . 0.0 110.849 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.73 ' HB2' HG11 ' A' ' 45' ' ' VAL . . . -60.43 82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 196' ' ' GLN . 0.2 OUTLIER -134.34 108.53 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.245 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.45 -70.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.508 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.484 HD12 ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 40.34 98.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.113 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 -49.7 -27.88 5.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.79 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -117.95 170.88 8.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.742 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -48.55 -79.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.39 -65.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.8 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.68 -53.28 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 42.5 mt 59.81 27.35 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.913 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.819 0.342 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.16 29.83 6.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -119.45 -74.91 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.45 -57.12 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 t -79.58 79.28 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.77 -134.71 43.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 166.05 14.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.45 -156.25 44.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.515 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.85 -112.31 0.26 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 62.13 160.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.69 142.51 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -148.89 -58.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 66.66 -179.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -88.33 139.9 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.084 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.57 169.64 17.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.9 128.67 9.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.1 34.45 1.54 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.7 76.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.947 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -116.74 106.39 13.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.78 -86.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.514 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.83 141.06 4.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -50.35 -54.62 20.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.28 110.29 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.3 m0 62.89 137.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.79 102.34 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.23 35.63 1.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -106.47 168.84 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.42 148.07 23.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.449 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -140.83 92.11 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.0 110.985 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 29.8 p90 -108.81 96.22 6.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.67 114.51 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.4 t30 52.78 81.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 1.1 mttm 178.05 -52.01 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 33' ' ' LYS . 39.7 Cg_exo -60.73 166.93 9.26 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 35' ' ' THR . 95.0 m -152.84 68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.61 157.86 43.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.073 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.48 177.95 28.23 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.742 ' CD2' HG21 ' A' ' 126' ' ' VAL . 5.4 t-105 -50.98 115.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.709 0.29 . . . . 0.0 110.816 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.921 ' HA ' HD13 ' A' ' 194' ' ' ILE . 0.8 OUTLIER 68.7 -67.08 0.22 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.12 0.486 . . . . 0.0 110.556 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.509 ' CD2' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -133.66 174.26 4.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HD2' ' CD2' ' A' ' 40' ' ' HIS . 69.6 Cg_exo -38.88 156.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.639 2.226 . . . . 0.0 112.443 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 45' ' ' VAL . 79.2 m-20 -41.4 -39.04 1.36 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.771 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.543 ' N ' ' HE2' ' A' ' 46' ' ' MET . 0.3 OUTLIER -50.21 -38.24 39.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.661 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HD3' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -67.88 -23.84 65.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.647 0.26 . . . . 0.0 111.606 -179.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 197' ' ' ALA . 0.1 OUTLIER -95.61 -67.23 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.976 0.417 . . . . 0.0 111.044 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.543 ' HE2' ' N ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -54.67 -19.53 6.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -177.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.56 -80.52 1.5 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.177 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 43' ' ' ASP . 88.9 Cg_endo -85.28 -20.47 3.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.189 2.593 . . . . 0.0 112.773 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 138.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.135 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.966 ' O ' HG12 ' A' ' 126' ' ' VAL . 1.6 t -95.88 94.37 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.599 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 7.7 p -114.82 137.89 51.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.115 0.483 . . . . 0.0 111.531 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' HB3' ' N ' ' A' ' 186' ' ' LEU . 1.8 m-85 -145.84 164.45 31.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.861 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 54' ' ' VAL . 1.4 tm? -76.34 131.25 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.246 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.823 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -148.42 135.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.192 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.62 104.98 12.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.25 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.13 135.08 46.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.46 ' HG3' HG22 ' A' ' 179' ' ' ILE . 0.0 OUTLIER -122.79 108.65 13.26 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.893 -177.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 17.84 -136.43 0.01 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 124.396 1.06 . . . . 0.0 115.149 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 178' ' ' HIS . 18.6 p -148.38 124.77 10.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.726 0.298 . . . . 0.0 111.221 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 179' ' ' ILE . 16.9 m -92.99 112.01 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 1.2 tt0 -85.23 147.58 26.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG13 ' H ' ' A' ' 110' ' ' LEU . 21.6 t -143.06 117.09 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.242 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.51 41.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.72 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.765 ' CB ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -64.16 157.9 24.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.085 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 m -98.67 -171.18 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.746 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.4 mmt -93.62 32.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.173 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.74 60.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.065 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.503 ' CB ' HG23 ' A' ' 109' ' ' ILE . . . -105.93 151.39 24.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.85 HD13 ' N ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 59.65 141.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.422 178.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.85 ' N ' HD13 ' A' ' 69' ' ' LEU . 1.3 m-20 -85.06 63.09 7.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.911 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.74 -66.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.376 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 73' ' ' THR . 11.2 m120 -164.36 -40.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 1.09 HG21 HG21 ' A' ' 109' ' ' ILE . 0.2 OUTLIER 86.94 5.05 0.35 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.132 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HG2' ' HB3' ' A' ' 72' ' ' ASN . 21.4 mmt180 -55.77 -62.43 1.7 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.554 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 76' ' ' GLN . 28.1 p -56.26 -67.18 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.212 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.732 ' NE2' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -36.72 -57.22 0.8 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.035 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.896 HG23 HG22 ' A' ' 73' ' ' THR . 58.4 t -57.1 -75.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.235 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 -41.43 31.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.59 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.058 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.4 tp10 -77.81 -23.8 48.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.468 ' HB1' ' HB ' ' A' ' 60' ' ' VAL . . . -70.37 -50.63 36.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.917 ' O ' HG12 ' A' ' 85' ' ' VAL . 58.1 mt -69.08 -52.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.339 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.697 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 45.6 t -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.977 0.418 . . . . 0.0 109.911 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' N ' ' A' ' 113' ' ' SER . 12.6 tp -74.48 -44.93 49.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.667 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.917 HG12 ' O ' ' A' ' 82' ' ' ILE . 8.0 p -58.58 -26.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.751 0.31 . . . . 0.0 110.317 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.823 ' HB2' HG22 ' A' ' 96' ' ' THR . 3.7 m -75.69 -43.9 44.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.827 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -53.83 -31.61 49.94 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.069 ' HB1' HD22 ' A' ' 115' ' ' LEU . . . -80.62 -62.79 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.207 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.744 HG11 ' CB ' ' A' ' 118' ' ' ALA . 6.3 p -111.63 70.23 0.85 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.277 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 86' ' ' CYS . 30.1 Cg_endo -62.65 -11.91 25.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.649 2.233 . . . . 0.0 112.802 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.97 -25.26 7.25 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.058 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -103.49 84.67 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.586 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -44.03 120.6 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.8 -63.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.212 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 83' ' ' SER . . . -119.18 -31.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.712 0.292 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.823 HG22 ' HB2' ' A' ' 86' ' ' CYS . 4.4 t -137.19 -158.0 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.485 ' N ' HG23 ' A' ' 96' ' ' THR . 4.4 ttt180 170.8 142.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.147 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.3 -71.81 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.025 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -163.72 165.23 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.102 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -177.53 134.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 31.5 Cg_exo -58.72 -66.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.436 2.091 . . . . 0.0 112.348 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 m 51.88 176.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.74 -82.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -159.12 155.87 25.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HG2' HD11 ' A' ' 109' ' ' ILE . 9.8 Cg_endo -51.95 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.731 2.287 . . . . 0.0 112.827 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -56.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.669 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 6.7 t -92.4 -160.51 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.524 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.44 -1.5 18.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.264 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.09 HG21 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -63.5 161.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.689 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER 83.47 142.76 0.07 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.343 -178.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.27 -71.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.894 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -177.11 138.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.922 0.361 . . . . 0.0 111.638 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.515 ' N ' HD21 ' A' ' 84' ' ' LEU . 18.3 p -99.64 134.4 42.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.264 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -97.43 129.74 44.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.069 HD22 ' HB1' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -111.9 64.11 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -55.0 5.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.97 0.415 . . . . 0.0 110.479 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -143.21 61.26 1.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.311 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.744 ' CB ' HG11 ' A' ' 89' ' ' VAL . . . -73.77 151.31 40.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.811 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.33 65.61 3.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.828 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.676 ' HE1' HG21 ' A' ' 122' ' ' ILE . 5.7 ttt -125.51 106.98 26.83 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 120.511 0.196 . . . . 0.0 110.688 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.427 ' C ' HG23 ' A' ' 122' ' ' ILE . 58.3 Cg_exo -57.22 122.56 12.01 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.347 2.031 . . . . 0.0 112.6 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.676 HG21 ' HE1' ' A' ' 120' ' ' MET . 1.5 pp -155.13 163.51 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.087 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.98 108.75 20.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.058 0.456 . . . . 0.0 111.239 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.71 HD21 HD23 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -92.57 126.19 37.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.251 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.45 ' N ' HD23 ' A' ' 124' ' ' LEU . 63.7 m -109.77 121.35 45.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.993 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.015 HG23 HD11 ' A' ' 131' ' ' LEU . 12.1 p -101.62 126.81 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.23 161.8 33.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.606 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.575 ' HA ' ' HB1' ' A' ' 197' ' ' ALA . 1.3 p -54.56 104.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.019 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' HD12 ' A' ' 200' ' ' LEU . 66.7 m 56.42 50.86 12.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.94 109.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -116.16 112.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.64 135.09 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD12 HD23 ' A' ' 124' ' ' LEU . 7.7 mp -105.9 158.34 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 141' ' ' ILE . 0.8 OUTLIER -139.49 114.22 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.869 ' HB1' ' HB2' ' A' ' 138' ' ' CYS . . . -57.24 109.62 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.668 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 122' ' ' ILE . . . -73.61 -60.18 2.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.424 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.23 -38.35 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.869 ' HB2' ' HB1' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -61.42 -19.7 62.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.519 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 138' ' ' CYS . 4.4 mttm 68.45 48.11 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.849 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' ' 135' ' ' ALA . 14.3 pt20 -159.66 -168.93 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.333 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 134' ' ' MET . 6.6 mt -132.41 139.72 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.814 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -101.96 125.69 56.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.6 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -106.06 111.69 24.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.41 91.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -136.34 56.91 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -33.49 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.049 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.4 mtt -122.61 146.79 47.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.56 68.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.739 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.94 105.58 6.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.973 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' ' 150' ' ' ILE . 0.1 OUTLIER -143.47 94.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.4 p -126.11 -83.13 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 153' ' ' ALA . 0.9 OUTLIER -104.04 126.44 51.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 167' ' ' VAL . . . 175.09 -64.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.5 t -161.61 62.37 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -48.53 -51.19 22.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.67 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.75 44.21 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.404 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 158' ' ' PRO . 2.3 m-20 -154.76 -66.82 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.46 0.172 . . . . 0.0 111.158 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 157' ' ' ASP . 73.4 Cg_endo -76.02 95.11 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.345 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 160' ' ' THR . 0.6 OUTLIER -157.2 -59.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 159' ' ' ASP . 0.8 OUTLIER -172.48 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -174.8 -67.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.151 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.21 42.29 3.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.993 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -133.32 144.34 49.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 190' ' ' VAL . 2.3 t -101.47 126.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.272 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.694 ' HB2' HD11 ' A' ' 82' ' ' ILE . . . -115.64 140.74 48.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.512 ' OH ' HD22 ' A' ' 180' ' ' LEU . 2.7 m-85 -119.64 159.02 25.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.991 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 153' ' ' ALA . 13.4 p -129.22 134.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -144.15 110.43 5.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -149.91 80.59 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.469 ' CB ' ' HD3' ' A' ' 171' ' ' PRO . 0.4 OUTLIER -75.29 -64.03 0.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.767 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 170' ' ' ASP . 98.8 Cg_endo -78.17 177.37 8.86 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.227 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 172' ' ' VAL . 14.8 p -113.02 41.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.82 41.04 1.01 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 180.0 -79.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.453 ' HB2' ' NH1' ' A' ' 175' ' ' ARG . 2.3 mtp-105 54.0 103.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -137.71 161.92 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 60' ' ' VAL . 87.6 m -120.8 162.89 19.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 9.3 m-70 -130.75 157.42 42.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.611 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.69 HD12 HG12 ' A' ' 82' ' ' ILE . 49.5 mm -115.88 148.64 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.742 0.306 . . . . 0.0 111.068 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.577 HD11 ' HB ' ' A' ' 54' ' ' VAL . 1.1 tt -148.01 150.11 33.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.443 ' N ' ' HG ' ' A' ' 180' ' ' LEU . 2.9 tt0 -120.7 129.54 53.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.092 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.767 ' SG ' HG21 ' A' ' 190' ' ' VAL . 71.5 m -103.47 100.72 19.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 94.5 Cg_endo -85.41 64.32 5.89 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.797 2.331 . . . . 0.0 111.923 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 68.72 45.18 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 52' ' ' TYR . . . -132.38 -103.62 0.89 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.803 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 1.098 HD12 HG13 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -59.17 -18.81 39.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.294 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.655 ' HA ' HG22 ' A' ' 190' ' ' VAL . . . -33.88 -33.17 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.599 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 186' ' ' LEU . 9.5 mt-30 -52.16 -47.77 65.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.567 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.623 ' HA ' HD12 ' A' ' 194' ' ' ILE . 5.3 t70 -90.23 -41.82 11.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 1.098 HG13 HD12 ' A' ' 186' ' ' LEU . 13.4 m -69.39 -14.89 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 187' ' ' ALA . 4.3 tp -92.13 -44.41 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -109.15 -29.93 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.484 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 189' ' ' ASP . 3.1 m 68.8 56.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 110.478 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.921 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.6 mp -44.64 -42.09 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.509 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -162.1 -143.51 3.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 198' ' ' PHE . 0.6 OUTLIER -166.68 115.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.773 0.32 . . . . 0.0 110.849 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.73 ' HB2' HG11 ' A' ' 45' ' ' VAL . . . -60.43 82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 196' ' ' GLN . 0.2 OUTLIER -134.34 108.53 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.245 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.45 -70.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.508 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.484 HD12 ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 40.34 98.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.113 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 -49.7 -27.88 5.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.79 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -117.95 170.88 8.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.742 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -48.55 -79.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.39 -65.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.8 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.68 -53.28 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 42.5 mt 59.81 27.35 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.913 179.863 . . . . . . . . 1 1 . 1 stop_ save_